Mycog
Mycog has been studied in 3 papers since 2023: 1 trial and 2 observational studies in people; 1 in the past year. The newest paper, Dec 24, 2025: “Leveraging the NIH Toolbox for Early Detection of Cognitive Impairment in Primary Care: The Toolbox Detect Trial”.
3 papers study it1 findingUpdated
“MyCog had a sensitivity of 79% and specificity of 82%, offering a practical, scalable, primary care assessment for the routine case finding of cognitive impairment and dementia.”
- 1 lab in 1 country
- Funders: National Institute of Neurological Disorders and Stroke and 1 more
- 1 of 1 finding with company ties
- Human trial1
- Humans2
What is Mycog linked with?
1Studies link Mycog with 1 measure, most often cognitive impairment (1 study).
Cognitive impairment
upin humans1
1 study
Cognitive impairment
upin humans1
Mycog predicts cognitive impairment in humans (sensitivity 79%, specificity 82%).
“MyCog had a sensitivity of 79% and specificity of 82%, offering a practical, scalable, primary care assessment for the routine case finding of cognitive impairment and dementia.”
Human trialn = 80
Gerontology & geriatric medicine
Funding
3 grants since 2018National Institute of Neurological Disorders and StrokeUS$6.5mNational Institute on AgingUS$1.6m
National Institute of Neurological Disorders and StrokeNorthwestern UniversityUS$1.5m2017–2027
National Institute on AgingNorthwestern UniversityUS$783.8k2021–2026
MyCog - Rapid detection of cognitive impairment in everyday clinical settings
National Institute of Neurological Disorders and StrokeNorthwestern UniversityUS$1.3m2017–2022